Qube Research & Technologies LTD Eye Point Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$8.16 - $22.89 $890,158 - $2.5 Million	109,088 Added 1833.72%	115,037 $1 Million
Q1 2024 May 14, 2024	BUY	$19.93 - $29.71 $118,563 - $176,744	5,949 New	5,949 $122,000
Q3 2023 Nov 13, 2023	BUY	$7.99 - $15.36 $80,746 - $155,228	10,106 New	10,106 $80,000
Q1 2022 May 09, 2022	SELL	$8.67 - $14.11 $338,476 - $550,854	-39,040 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$10.18 - $18.4 $397,427 - $718,336	39,040 New	39,040 $478,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $357M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.